Browsing by Author "Overbeck, T.R."
Now showing 1 - 3 of 3
- Results Per Page
- Sort Options
- Some of the metrics are blocked by yourconsent settings110P Updated efficacy and safety of entrectinib in patients (pts) with NTRK fusion-positive (NTRK-fp) NSCLC(2022)
;Cho, B.C. ;Chiu, C-H. ;Massarelli, E. ;Chawla, S.P. ;Buchschacher, G.L. ;Goto, K. ;Kim, S-W. ;Overbeck, T.R. ;Loong, H.H.F. ;Chee, C.E. - Some of the metrics are blocked by yourconsent settings1988MO Recruitment discontinuation in TREASURE trial (thoracic radiotherapy with atezolizumab in small cell lung cancer extensive disease) due to unexpected safety data(2023)
;Bozorgmehr, F. ;Weykamp, F. ;Overbeck, T.R. ;Maguire, N. ;Buchmeier, E.L. ;Hammer-Hellmig, M. ;Gauler, T.C. ;Wermke, M. ;Troost, E.G.C. ;Ulmer, M.Rieken, S. - Some of the metrics are blocked by yourconsent settings364O Intracranial efficacy of entrectinib in patients with NTRK fusion-positive solid tumours and baseline CNS metastases(2020)
; ;Chiu, C-H. ;Cho, B.C. ;Fakih, M. ;Farago, A.F. ;Demetri, G.D. ;Goto, K. ;Doebele, R.C. ;Siena, S. ;Drilon, A. ;Patel, M.R. ;Liu, S.V. ;Ahn, M-J. ;Bazhenova, L. ;Overbeck, T.R. ;Nieva, J. ;Kim, S-W. ;Veronese, L. ;Day, B-M.De Braud, F.